These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9715381)

  • 1. [Progressive systemic scleroderma--prognosis determining involvement of internal organ systems].
    Mittag M; Haustein UF
    Hautarzt; 1998 Jul; 49(7):545-51. PubMed ID: 9715381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.
    Poormoghim H; Andalib E; Jalali A; Ghaderi A; Ghorbannia A; Mojtabavi N
    Rheumatol Int; 2016 Jul; 36(7):925-34. PubMed ID: 27061806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical approach to scleroderma.
    White B
    Semin Cutan Med Surg; 1998 Sep; 17(3):213-8. PubMed ID: 9759679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
    Ooi C; Solanki K; Lao C; Frampton C; White D
    Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal and extra-renal involvement in sclerodermia].
    Visconti L; Atteritano M; Buemi M; Santoro D
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in causes of death in systemic sclerosis, 1972-2002.
    Steen VD; Medsger TA
    Ann Rheum Dis; 2007 Jul; 66(7):940-4. PubMed ID: 17329309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study.
    Wangkaew S; Lertthanaphok S; Puntana S; Noppakun K
    Int J Rheum Dis; 2017 Oct; 20(10):1562-1571. PubMed ID: 28752678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
    Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
    Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases.
    Shalev T; Haviv Y; Segal E; Ehrenfeld M; Pauzner R; Levy Y; Langevitz P; Shoenfeld Y
    Clin Exp Rheumatol; 2006; 24(4):380-6. PubMed ID: 16956427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visceral manifestations of diffuse scleroderma].
    Suţeanu S; Moise A; Stoicescu M
    Med Interne; 1988; 26(2):125-38. PubMed ID: 3291079
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
    Ng K; Gow P
    N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New trends in diagnosis and treatment of systemic sclerosis].
    Becvár R; Stork J; Jansa P
    Vnitr Lek; 2006; 52(7-8):712-7. PubMed ID: 16967613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart involvement and pulmonary arterial hypertension in patients with systemic sclerosis].
    Cikes N
    Reumatizam; 2010; 57(2):99-104. PubMed ID: 21875012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.